EDUCATION AND TRAINING

Cardiology and Clinical Cardiac Electrophysiology Fellow, Sarnoff Scholar, Duke University Medical Center, Durham, NC, 1987–1990.

Intern and Resident, Department of Medicine, Massachusetts General Hospital, Boston, MA, 1984–1987.

B.S., Magna Cum Laude, Zoology, Duke University, Durham, NC, 1980.

Stanley J. Sarnoff Fellowship, Department of Pharmacology, Columbia Presbyterian Medical Center, New York, NY, 1982–1983.

M.D., Duke University, Durham, NC, 1984.

Richard L. Page M.D., F.A.C.C., F.A.H.A., F.H.R.S.
Professor and Head, Division of Cardiology
Robert A. Bruce Endowed Chair in Cardiovascular Research, University of Washington School of Medicine

BOARD CERTIFICATION

Diplomat, Subspecialty of Cardiovascular Disease, 1989.

Diplomat, Subspecialty of Clinical Cardiac Electrophysiology, 1992, 2002.

Diplomat, American Board of Internal Medicine, 1987.

Diplomat, National Board of Medical Examiners, 1985.

AREAS OF CLINICAL EXPERTISE

Sudden cardiac death

Atrial fibrillation

Syncope

Arrhythmias

CURRENT RESEARCH INTERESTS

Drug therapy for atrial fibrillation

Asymptomatic atrial fibrillation

Automated external defibrillators

SPECIAL ACCOMPLISHMENTS

Who's Who in America 1997–present.

Recipient of Dallas Heart Ball Endowed Chair in Cardiac Arrhythmia Research, 1997.

Board of Trustees, North American Society of Pacing and Electrophysiology 2001–present, Treasurer 2003–present.

2001 Distinguished Physician Award, Parkland Health and Hospital System.

Best Doctors in America 2002–present.

Robert A. Bruce Endowed Chair in Cardiovascular Research, 2002.

Association of University Cardiologists, 2004.

Service Excellence Award, University of Washington Medical Center, 2004.

Alpha Omega Alpha, Medical Honor Society, 1984.

Board of Directors, Stanley J. Sarnoff Endowment for Research in Cardiovascular Science, Inc., 1990– present.

RECENT PUBLICATIONS

Page, RL, Hamdan, MH, McKenas, DK. Defibrillation aboard a commercial aircraft. Circulation. 97:1429–1430, 1998.

Kern, KB, Paraskos, JA (Co-chairs), Task Force 1: Cardiac arrest, 31st Bethesda Conference: Emergency cardiac care (1999). J. Am. Coll. Cardiol. 35:825–880, 2000.

Smith, ML, Joglar, JA, Wasmund, SL, Carlson, MD, Welch, PJ, Hamdan, MH, Page, RL. Reflex control of sympathetic activity during simulated ventricular tachycardia in humans. Circulation. 100:628–634, 1999.

Joglar, JA, Hamdan, MH, Ramaswamy, K, Zagrodzky, JD, Sheehan, CJ, Nelson, LL, Andrews, TC, Page, RL. Initial energy for external cardioversion of atrial fibrillation. Am. J. Cardiol. 86:348–350, 2000.

Page, RL. Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function. Am. J. Cardiol. 85:1481–1485, 2000.

Page, RL, Joglar, JA, Kowal, RC, Zagrodzky, JD, Nelson, LL, Ramaswamy, K, Barbera, SJ, Hamdan, MH, McKenas, DK. Automated external defibrillator use aboard a U.S. airline. New Engl. J. Med. 343:1210–1216, 2000.

Page, RL. Beta-blockers for atrial fibrillation: Must we consider asymptomatic arrhythmias? J. Am. Coll. Cardiol. 36:147–150, 2000.

Hamdan, MH, Zagrodzky, JD, Page, RL, Joglar, JA, Wasmund, SL, Sheehan, CJ, Adamson, M, Smith, ML. The effect of P wave timing during supraventricular tachycardia on the hemodynamic and sympathetic neural response. Circulation. 103:96–101, 2001.

Takata, T, Page, RL, Joglar, JA. Automated external defibrillators: Technical considerations and clinical promise. Ann. Int. Med. 135:990–998, 2001.

Joglar, JA, Page, RL. Antiarrhythmic drugs in pregnancy. Curr. Opin. Cardiol. 16:40–45, 2001.

Page, RL, Connolly, SJ, Wilkinson, WE, Marcello, SR, Schnell, DJ, Pritchett. ELC and the Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators, Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: Efficacy and dose-response. Am. Heart J. 143:643–649, 2002.

Page, RL, Kerber, RE, Russell, JK, Trouton, T, Waktare, J, Gallik, D, Olgin, JE, Ricard, P, Dalzell, GW, Reddy, R, Lazzara, R, Lee, K, Carlson, M, Halperin, B, Bardy, GH, for the BiCard Investigators, Biphasic vs monophasic shock waveform for conversion of atrial fibrillation, the results of an international randomized, double-blind multicenter trial. J. Am. Coll. Cardiol. 39:1956–1963, 2002.

Joglar, JA, Page, RL. Automated external defibrillator use by police responders: Where do we go from here? Circulation. 106:1030–1033, 2002.

Page, RL, Tilsh, TW, Connolly, SJ, Schnell, DJ, Marcello, SR, Wilkinson, WE, Pritchett. ELC, Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation. 107:1141–1145, 2003.

Page, RL, Zipes, DP, Powell, JL, Luceri, RM, Gold, MR, Peters, R, Russo, AM, Bigger, JT, Sung, RJ, McBurnie, MA, and the AVID Investigators. Seasonal variation of mortality in the antiarrhythmics versus implantable defibrillators (AVID) study registry. Heart Rhythm 1:435–440, 2004.

Page, RL. Newly-diagnosed atrial fibrillation. New Engl. J. Med. 351:2408-2416, 2004.

Page, RL, Roden, D. Drug therapy for atrial fibrillation: Where do we go from here? Nat. Rev. Drug Discov. 4:899–910, 2005.

Page, RL. Antiarrhythmic drugs for all patients with an ICD? JAMA 295:211–213, 2006.

Hillis, LD, Lange, RA, Winniford, MD, Page, RL. Manual of Clinical Problems in Cardiology (6th edition), Lippincott Williams & Wilkins: Philadelphia, 2003.